Arbutus Biopharma Corp·4

Feb 17, 4:57 PM ET

Howard Elizabeth 4

4 · Arbutus Biopharma Corp · Filed Feb 17, 2021

Insider Transaction Report

Form 4
Period: 2021-02-13
Howard Elizabeth
Exec. VP & General Counsel
Transactions
  • Award

    Stock Options

    2021-02-13+200,000200,000 total
    Exercise: $4.33Exp: 2031-02-13Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]The stock option will vest and become exercisable 1/48th each month over the four year period.

Documents

2 files
  • 4
    wf-form4_161359901972313.xmlPrimary

    FORM 4

  • EX-24

    POA - HOWARD